Company / Revenue per Share
Prime Medicine, Inc. Revenue per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.03
FY2024
5-year range
$0.00 / $1.97
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#141 of 148
Health Care
What the data says
Among 148 Health Care companies, Prime Medicine, Inc. is in the bottom 5% for revenue per share. Improved from $0.00 to $0.03 over the past 2 years.
Based on SEC 10-K filings.
0.03 in FY2024.
Improved from $0.00 to $0.03 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 148This company $0.03 Sector average $20.24
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #141 out of 148 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2020.
- Lowest revenue per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.03 | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | -100.0% |
| FY2020 | $1.97 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026